FDA approves first natalizumab biosimilar for MS treatment

Dr. Barbara Giesser, neurologist and MS specialist at Pacific Neuroscience Institute at Providence Saint John’s Health Center in Santa Monica, CA, explained to Medical News Today: “Tyruko is a biosimilar form of a medicine that has been around for ...